Pfizer
Pfizer Inc. is an American pharmaceutical company that made international headlines in 2020 for developing a COVID-19 mRNA vaccine that would reach the world.
Founded by German immigrants and headquartered in New York, Pfizer produces and also develops a variety of medicines. Pfizer's CEO is Albert Bourla, a Sephardic Jew.
On December 27, 2020, thousands of Pfizer vaccines arrived in Israel, kicking off the country's vaccination campaign.
Former Pfizer chief scientist joins Immunai’s board of directors
Biotech company Immunai, which developed an AI-based immune system mapping technology for drug development, announces the appointment of Dr. Mikael Dolsten to its board of directors.
Former Pfizer R&D chief Mikael Dolsten joins Immunai’s board of directors
Israel Bonds honors Pfizer CEO Albert Bourla for contributions to health, support for Israel
Grapevine January 31, 2024: The courage of her convictions
Israeli-American blueprint for future pandemic medications
An open-access format for drug discovery is helping design medications at lower prices against potential viral threats to mankind.
Antibiotic shortages expected to worsen syphilis epidemic - NYT
Pfizer announced that there would be shortages of Bicillin L-A last month. Bicillin L-A is a long-acting injectable antibiotic that is also known as penicillin G benzathine.
Pfizer scraps one weight loss drug in race to develop Ozempic rival
The company's shares fell 3.5% in volatile premarket trading on Monday as Pfizer said it would stop developing its therapy lotiglipron.
Pfizer expects to run out of antibiotic supply soon
Supply of the drug, Bicillin L-A, is expected to be exhausted by the end of this quarter, the company said in a letter to the US health regulator dated Monday.
Pfizer pouring COVID profits into cancer battle, CEO Bourla says
The COVID products drove Pfizer's revenue to record levels, topping $100 billion in 2022 and $80 billion in 2021.
Got migraines? FDA approved Pfizer's nasal spray treatment
Every day, there are 40,000 migraine attacks in Israel. This new Pfizer treatment could help
Arbutus files patent infringement lawsuit against Pfizer/BioNTech over COVID shots
The lawsuit by Arbutus and Genevant says Pfizer/BioNTech engaged in licensing discussions for the technology but they did not "result in a settlement."
Pfizer's COVID vaccine factory: Witnessing a modern miracle
Pfizer’s COVID-19 vaccine was the first shot approved by the US Food & Drug Administration (FDA) for Emergency Use, and Israel was the first country to mass vaccinate its population.
Sleeping less than six hours will decrease vaccine effectiveness - study
The multi-institution study, published in the peer-reviewed academic journal Current Biology, sheds light on the link between sleep duration and antibody response.
mRNA could make flu vaccines more effective - here's how
The World Health Organization reported that as many as 5 million people suffer from severe cases of influenza each year.
Could vaccines be a cure for antibiotic-resistant bacteria?
Israeli scientists announce 100% effectiveness of mRNA vaccine against Black Plague-causing bacteria in preclinical trial performed on mice.
